Dr. Carl T D'Angio, MD
Claim this profileUniversity of Rochester
Studies Premature Infants
Studies Preterm Birth
10 reported clinical trials
16 drugs studied
Affiliated Hospitals
Clinical Trials Carl T D'Angio, MD is currently running
Cycled Phototherapy
for Premature Infants
Cycled phototherapy (PT) is likely to increase survival over that with continuous PT among extremely premature infants (\< 750 g BW or \<27 weeks GA).
Recruiting1 award N/A3 criteria
Antibiotics
for Neonatal Infections
The goal of the NANO trial is to study the longstanding clinical practice of empirically administering intravenous antibiotics to extremely low birthweight (ELBW) infants in the first days of life. In this 802-subject multicenter placebo-controlled randomized clinical trial, the hypothesis to be tested is that the incidence of adverse outcomes is higher in babies receiving empiric antibiotics (EA) in the first week of life compared to babies receiving placebo. The study targets a population of ELBW infants in whom the clinical decision to use or not use EA is currently most challenging -- infants that are clinically stable that did not have a known exposure to intraamniotic infection and were not born preterm for maternal indications. The primary outcome is the composite outcome of late-onset sepsis (LOS), necrotizing enterocolitis (NEC), or death during the index hospitalization. Secondary safety outcomes will include total antibiotic days, days to full enteral feedings, and common morbidities in preterm infants that have previously been linked to EA, e.g. retinopathy of prematurity and bronchopulmonary dysplasia. Weight and length z-score, and head circumference, are standard measures to be collected weekly by clinical team per a standardized protocol.
Recruiting2 awards Phase 41 criteria
More about Carl T D'Angio, MD
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Carl T D'Angio, MD has experience with
- None
- Placebo
- Ampicillin
- Liberal Cell Transfusion
- Restricted Red Cell Transfusion
- Caffeine Citrate
Breakdown of trials Carl T D'Angio, MD has run
Premature Infants
Preterm Birth
Low Birth Weight
Small for Gestational Age
Bronchopulmonary Dysplasia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Carl T D'Angio, MD specialize in?
Carl T D'Angio, MD focuses on Premature Infants and Preterm Birth. In particular, much of their work with Premature Infants has involved treating patients, or patients who are undergoing treatment.
Is Carl T D'Angio, MD currently recruiting for clinical trials?
Yes, Carl T D'Angio, MD is currently recruiting for 3 clinical trials in Rochester New York. If you're interested in participating, you should apply.
Are there any treatments that Carl T D'Angio, MD has studied deeply?
Yes, Carl T D'Angio, MD has studied treatments such as None, Placebo, Ampicillin.
What is the best way to schedule an appointment with Carl T D'Angio, MD?
Apply for one of the trials that Carl T D'Angio, MD is conducting.
What is the office address of Carl T D'Angio, MD?
The office of Carl T D'Angio, MD is located at: University of Rochester, Rochester, New York 14642 United States. This is the address for their practice at the University of Rochester.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.